Top Buy
| Security | Buy | Sell | Buy (1W) ▲ | Sell (1W) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Emergent Biosolutions Inc. | 2 | 3 | 0 | 0 | €3.61 | €4.62 | 27.895% |
| Perrigo Co. plc | 3 | 0 | 0 | 0 | €30.83 | €35.99 | 16.722% |
| MorphoSys AG | 7 | 0 | 0 | 0 | €66.75 | €65.00 | -2.622% |
| Dr. Reddy's Laboratories Ltd. ADR | 5 | 1 | 0 | 0 | €69.50 | €73.92 | 6.360% |
| Sartorius AG VZO | 4 | 0 | 0 | 0 | €285.40 | - | - |
| Nektar Therapeutics | 3 | 1 | 0 | 0 | €1.46 | €3.70 | 152.732% |
| Haemonetics Corp. | 7 | 0 | 0 | 0 | €84.50 | €97.90 | 15.860% |
| Medpace Holdings Inc | 9 | 0 | 0 | 0 | €365.20 | €421.61 | 15.445% |
| Viatris Inc. | 1 | 0 | 0 | 0 | €10.96 | - | - |
| CONMED Corp. | 11 | 1 | 0 | 0 | €63.00 | €109.59 | 73.944% |
| Ensign Group Inc. | 8 | 0 | 0 | 0 | €109.00 | €116.50 | 6.877% |
| Icon plc | 18 | 0 | 0 | 0 | €280.90 | €319.67 | 13.802% |
| QIAGEN NV | 9 | 0 | 0 | 0 | €40.47 | €47.44 | 17.223% |
| Gerresheimer AG | 7 | 0 | 0 | 0 | €102.10 | €110.00 | 7.738% |
| Icu Medical Inc. | 3 | 0 | 0 | 0 | €90.50 | €124.85 | 37.953% |
| Xencor Inc. | 9 | 1 | 0 | 0 | €18.70 | €31.74 | 69.727% |
| Iovance Biotherapeutics Inc. | 19 | 3 | 0 | 0 | €12.68 | €25.20 | 98.839% |
| Healthequity Inc. | 1 | 0 | 0 | 0 | €73.50 | €79.00 | 7.483% |
| Charles River Labs Intl | 9 | 0 | 0 | 0 | €216.90 | €247.61 | 14.157% |
| Integer Hldg | 1 | 0 | 0 | 0 | €101.00 | - | - |
| Taro Pharmaceutical Industries Ltd | 7 | 0 | 0 | 0 | €39.40 | - | - |
| Hutchison China MediTech Ltd ADR | 5 | 0 | 0 | 0 | €18.30 | €45.10 | 146.421% |
| Catalent Inc. | 2 | 0 | 0 | 0 | €52.32 | €55.00 | 5.122% |
| Bruker Corp. | 7 | 1 | 0 | 0 | €65.08 | €85.68 | 31.660% |
| Myriad Genetics | 5 | 2 | 0 | 0 | €18.10 | €23.22 | 28.273% |